Lotte Bjerre Knudsen

15.2k total citations · 11 hit papers
105 papers, 10.5k citations indexed

About

Lotte Bjerre Knudsen is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Lotte Bjerre Knudsen has authored 105 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Endocrinology, Diabetes and Metabolism, 50 papers in Molecular Biology and 47 papers in Surgery. Recurrent topics in Lotte Bjerre Knudsen's work include Diabetes Treatment and Management (73 papers), Pancreatic function and diabetes (45 papers) and Metabolism, Diabetes, and Cancer (28 papers). Lotte Bjerre Knudsen is often cited by papers focused on Diabetes Treatment and Management (73 papers), Pancreatic function and diabetes (45 papers) and Metabolism, Diabetes, and Cancer (28 papers). Lotte Bjerre Knudsen collaborates with scholars based in Denmark, United States and United Kingdom. Lotte Bjerre Knudsen's co-authors include Jesper Lau, Charles Pyke, Kjeld Madsen, Niels Vrang, Michael Wilken, Steffen Reedtz‐Runge, Mads Tang‐Christensen, C. F. Gotfredsen, Kirsten Raun and Bidda Rolin and has published in prestigious journals such as Nature, JAMA and Journal of Biological Chemistry.

In The Last Decade

Lotte Bjerre Knudsen

103 papers receiving 10.1k citations

Hit Papers

Discovery of the Once-Wee... 2000 2026 2008 2017 2015 2014 2014 2019 2000 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
    2015 736 citations Lotte Bjerre Knudsen et al. profile →
  2. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
    2014 702 citations Anna Secher, Jacob Jelsing et al. Journal of Clinical Investigation profile →
  3. GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
    2014 660 citations Charles Pyke, Lotte Bjerre Knudsen et al. Endocrinology profile →
  4. The Discovery and Development of Liraglutide and Semaglutide
    2019 601 citations Lotte Bjerre Knudsen et al. profile →
  5. Potent Derivatives of Glucagon-like Peptide-1 with Pharmacokinetic Properties Suitable for Once Daily Administration
    2000 579 citations Lotte Bjerre Knudsen et al. profile →
  6. Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
    2010 507 citations Lotte Bjerre Knudsen, Søren Andersen et al. Endocrinology profile →
  7. The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE−/− and LDLr−/− Mice by a Mechanism That Includes Inflammatory Pathways
    2018 350 citations Joseph Polex-Wolf, Lotte Bjerre Knudsen et al. JACC Basic to Translational Science profile →
  8. Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers
    2022 134 citations Lotte Bjerre Knudsen et al. profile →
  9. Using genetic association data to guide drug discovery and development: Review of methods and applications
    2023 60 citations Stephen Burgess, Verena Zuber et al. profile →
  10. A comprehensive spatio-cellular map of the human hypothalamus
    2025 29 citations John A. Tadross, Lukas Steuernagel et al. Nature profile →
  11. Proteomic changes upon treatment with semaglutide in individuals with obesity
    2025 20 citations Lasse Maretty, Dipender Gill et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lotte Bjerre Knudsen Denmark 50 7.1k 4.4k 3.6k 1.8k 1.5k 105 10.5k
Laurie L. Baggio Canada 46 7.2k 1.0× 3.5k 0.8× 4.4k 1.2× 1.6k 0.9× 1.6k 1.1× 70 10.3k
Yuichiro Yamada Japan 59 5.1k 0.7× 4.7k 1.1× 3.7k 1.0× 1.5k 0.8× 1.5k 1.0× 280 11.7k
Masatsugu Horiuchi Japan 67 4.6k 0.6× 5.8k 1.3× 1.7k 0.5× 1.2k 0.7× 1.9k 1.2× 267 14.3k
Christopher H.S. McIntosh Canada 50 5.3k 0.8× 2.9k 0.7× 3.5k 1.0× 2.7k 1.5× 694 0.5× 154 8.1k
Michael B. Wheeler Canada 68 4.0k 0.6× 6.0k 1.4× 6.6k 1.8× 1.3k 0.7× 3.3k 2.2× 204 13.5k
Carolyn F. Deacon Denmark 79 15.2k 2.2× 6.3k 1.4× 8.5k 2.3× 3.6k 2.1× 2.7k 1.8× 233 19.6k
Bei B. Zhang United States 38 2.3k 0.3× 3.9k 0.9× 2.2k 0.6× 534 0.3× 2.9k 1.9× 68 8.6k
Raymond A. Pederson Canada 44 4.8k 0.7× 2.3k 0.5× 3.0k 0.8× 2.5k 1.4× 566 0.4× 125 6.9k
Kyle W. Sloop United States 40 2.7k 0.4× 2.4k 0.5× 1.3k 0.3× 721 0.4× 1.2k 0.8× 89 5.1k
Albert Salehi Sweden 56 3.1k 0.4× 3.2k 0.7× 4.7k 1.3× 665 0.4× 1.3k 0.8× 162 7.8k

Countries citing papers authored by Lotte Bjerre Knudsen

Since Specialization
Citations

This map shows the geographic impact of Lotte Bjerre Knudsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lotte Bjerre Knudsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lotte Bjerre Knudsen more than expected).

Fields of papers citing papers by Lotte Bjerre Knudsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lotte Bjerre Knudsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lotte Bjerre Knudsen. The network helps show where Lotte Bjerre Knudsen may publish in the future.

Co-authorship network of co-authors of Lotte Bjerre Knudsen

This figure shows the co-authorship network connecting the top 25 collaborators of Lotte Bjerre Knudsen. A scholar is included among the top collaborators of Lotte Bjerre Knudsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lotte Bjerre Knudsen. Lotte Bjerre Knudsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tadross, John A., Lukas Steuernagel, Georgina K.C. Dowsett, et al.. (2025). A comprehensive spatio-cellular map of the human hypothalamus. Nature. 639(8055). 708–716. 29 indexed citations breakdown →
2.
Maretty, Lasse, Dipender Gill, Lotte Simonsen, et al.. (2025). Proteomic changes upon treatment with semaglutide in individuals with obesity. Nature Medicine. 31(1). 267–277. 20 indexed citations breakdown →
3.
Gill, Dipender, Dmitry Shungin, Christos S. Mantzoros, et al.. (2024). Robust use of phenotypic heterogeneity at drug target genes for mechanistic insights: Application of cis‐multivariable Mendelian randomization to GLP1R gene region. Genetic Epidemiology. 48(4). 151–163. 9 indexed citations
4.
Rupp, Alan C., Alison H. Affinati, Cadence True, et al.. (2023). Suppression of food intake by Glp1r/Lepr-coexpressing neurons prevents obesity in mouse models. Journal of Clinical Investigation. 133(19). 29 indexed citations
5.
Withaar, Coenraad, Laura M G Meems, Elisabeth M. Schouten, et al.. (2023). The Cardioprotective Effects of Semaglutide Exceed Those of Dietary Weight Loss in Mice With HFpEF. JACC Basic to Translational Science. 8(10). 1298–1314. 40 indexed citations
6.
Karhunen, Ville, Iyas Daghlas, Verena Zuber, et al.. (2021). Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling. Diabetologia. 64(12). 2773–2778. 17 indexed citations
7.
Farkas, Erzsébet, Anett Szilvásy‐Szabó, Morten G. Rasch, et al.. (2020). Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brain. Brain Structure and Function. 226(1). 225–245. 48 indexed citations
8.
Hansen, Henrik H., Katrine Fabricius, Pernille Barkholt, et al.. (2016). Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer’s Disease. PLoS ONE. 11(7). e0158205–e0158205. 45 indexed citations
9.
Hansen, Henrik H., Pernille Barkholt, Katrine Fabricius, et al.. (2015). The GLP-1 receptor agonist liraglutide reduces pathology-specific tau phosphorylation and improves motor function in a transgenic hTauP301L mouse model of tauopathy. Brain Research. 1634. 158–170. 77 indexed citations
10.
Knauf, Jeffrey A., C. F. Gotfredsen, Andrew Pilling, et al.. (2012). GLP-1 Receptor Agonists and the Thyroid: C-Cell Effects in Mice Are Mediated via the GLP-1 Receptor and not Associated with RET Activation. Endocrinology. 153(3). 1538–1547. 112 indexed citations
11.
Nyborg, Niels C. Berg, et al.. (2012). The Human GLP-1 Analog Liraglutide and the Pancreas. Diabetes. 61(5). 1243–1249. 97 indexed citations
12.
Knudsen, Lotte Bjerre, Sven Hastrup, Christina Rye Underwood, Birgitte S. Wulff, & Jan Fleckner. (2012). Functional importance of GLP-1 receptor species and expression levels in cell lines. Regulatory Peptides. 175(1-3). 21–29. 27 indexed citations
13.
Gaspari, Tracey A., Iresha Welungoda, Yunshan Hu, et al.. (2011). A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model. Diabetes and Vascular Disease Research. 8(2). 117–124. 163 indexed citations
14.
Cummings, Bethany P., Kimber L. Stanhope, James L. Graham, et al.. (2010). Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats. Diabetes. 59(10). 2653–2661. 60 indexed citations
15.
Liu, Hongbin, Anthony E. Dear, Lotte Bjerre Knudsen, & Richard W Simpson. (2009). A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules. Journal of Endocrinology. 201(1). 59–66. 157 indexed citations
16.
Lykkegaard, Kirsten, Philip J. Larsen, Niels Vrang, et al.. (2008). The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance. Schizophrenia Research. 103(1-3). 94–103. 45 indexed citations
17.
Andersen, Ulf, et al.. (2003). Prediction of syneresis in yoghurt by means of Confocal Laser Scanning Microscopy (CLSM) and image analysis.. 313–320. 1 indexed citations
18.
Larsen, Philip J., Niels Vrang, Mads Tang‐Christensen, et al.. (2002). Ups and downs for neuropeptides in body weight homeostasis: pharmacological potential of cocaine amphetamine regulated transcript and pre-proglucagon-derived peptides. European Journal of Pharmacology. 440(2-3). 159–172. 17 indexed citations
19.
Holst, Jens J., et al.. (1998). On the Treatment of Diabetes Mellitus with Glucagon‐like Peptide‐1. Annals of the New York Academy of Sciences. 865(1). 336–343. 22 indexed citations
20.
Knudsen, Lotte Bjerre, et al.. (1979). [The short ACTH test and insulin hypoglycemia test in patients treated with glucocorticoids. A comparison].. PubMed. 141(17). 1139–40. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurie L. Baggio Breakdown of academic impact, for papers by Yuichiro Yamada Breakdown of academic impact, for papers by Masatsugu Horiuchi Breakdown of academic impact, for papers by Christopher H.S. McIntosh Breakdown of academic impact, for papers by Michael B. Wheeler Breakdown of academic impact, for papers by Carolyn F. Deacon Breakdown of academic impact, for papers by Bei B. Zhang Breakdown of academic impact, for papers by Raymond A. Pederson Breakdown of academic impact, for papers by Kyle W. Sloop Breakdown of academic impact, for papers by Albert Salehi
Rankless by CCL
2026